Date: 2023-01-05Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 224/2019 of 27 September 2019 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/29]
**Summary:**
EEA Joint Committee Decision No. 224/2019, adopted on September 27, 2019, amends Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement. This decision incorporates Commission Implementing Regulation (EU) 2019/238 of February 8, 2019, which amends Regulation (EU) No 37/2010 to classify the substance ovotransferrin regarding its maximum residue limit, into the EEA Agreement. The amendment is added as indent 32019 R 0238 to point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II. The text of Implementing Regulation (EU) 2019/238 in Icelandic and Norwegian will be published in the EEA Supplement to the Official Journal of the European Union and shall be authentic. The decision entered into force on September 28, 2019, following the completion of notifications under Article 103(1) of the EEA Agreement. The decision was published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union (OJ L 39, 11.2.2019, p. 4).
Key Entities Referenced
EEA Joint Committee: The decision-making body responsible for amending the EEA Agreement.
EEA Agreement: Agreement on the European Economic Area
Annex II: Annex II Technical regulations, standards, testing and certification to the EEA Agreement
Commission Implementing Regulation EU 2019/238: A regulation amending Regulation EU No 37/2010 to classify ovotransferrin.
Regulation EU No 37/2010: Regulation that is being amended by Commission Implementing Regulation EU 2019/238.
Ovotransferrin: Substance classified as regards its maximum residue limit.
Brussels: Location where the decision was made.
Gunnar PLSSON: The President of the EEA Joint Committee.
5.1.2023 EN Official Journal of the European Union L 4/39
DECISION OF THE EEA JOINT COMMITTEE No 224/2019
of 27 September 2019
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
[2023/29]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2019/238 of 8 February 2019amending Regulation (EU) No 37/2010
to classify the substance ovotransferrin as regards its maximum residue limit(1)is to be incorporated into the EEA
Agreement.
(2) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following indent is added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the
EEA Agreement:
‘— 32019 R 0238: Commission Implementing Regulation (EU) 2019/238 of 8 February 2019 (OJ L 39, 11.2.2019,
p. 4).’
Article 2
The text of Implementing Regulation (EU) 2019/238 in the Icelandic and Norwegian languages, to be published in the EEA
Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 28 September 2019, provided that all the notifications under Article 103(1) of the
EEA Agreement have been made(*).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
Done at Brussels, 27 September 2019.
For the EEA Joint Committee
The President
Gunnar PÁLSSON
(1) OJ L 39, 11.2.2019, p. 4.
(*) No constitutional requirements indicated.